CIK 0000875320
- Large accelerated filer
VERTEX PHARMACEUTICALS INC / MA
Sign in to watch- Ticker
- VRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 043039129
- Phone
- +1 617-341-6393
- Business address
- 50 NORTHERN AVENUE, BOSTON, MA, 02210
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $15,378,206
- in 4 filings, $15.4M under 10b5-1 plans
Net −$15,378,206. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-02 | LEIDEN JEFFREY M Executive Chairman | Sale 10b5-1 | −1,505 | $350.48 | $527K | 42,199 |
| 2023-05-02 | LEIDEN JEFFREY M Executive Chairman | Sale 10b5-1 | −300 | $353.18 | $106K | 41,899 |
| 2023-05-02 | Bhatia Sangeeta N. Director | Sale 10b5-1 | −62 | $345.93 | $21K | 5,146 |
| 2023-05-02 | Bhatia Sangeeta N. Director | Sale 10b5-1 | −172 | $346.69 | $60K | 4,974 |
| 2023-05-02 | Bhatia Sangeeta N. Director | Sale 10b5-1 | −120 | $348.16 | $42K | 4,854 |
| 2023-05-02 | Bhatia Sangeeta N. Director | Sale 10b5-1 | −163 | $349.82 | $57K | 4,691 |
| 2023-05-02 | Bhatia Sangeeta N. Director | Sale 10b5-1 | −63 | $351.20 | $22K | 4,628 |
| 2023-05-01 | Upadhyay Suketu Director | Grant or award | +1,168 | 2,726 | ||
| 2023-05-01 | SACHS BRUCE I Director | Grant or award · Stock Option (Right to Buy) | +3,481 | 3,481 | ||
| 2023-05-01 | MCKENZIE DIANA Director | Returned to the company | −1,449 | 1,435 | ||
| 2023-05-01 | MCKENZIE DIANA Director | Grant or award | +1,168 | 2,603 | ||
| 2023-05-01 | MCKENZIE DIANA Director | Grant or award · Deferred Stock Units | +1,449 | 4,566.52 | ||
| 2023-05-01 | MCGLYNN MARGARET G Director | Grant or award · Stock Option (Right to Buy) | +3,481 | 3,481 | ||
| 2023-05-01 | Lee Yuchun Director | Grant or award · Stock Option (Right to Buy) | +3,481 | 3,481 | ||
| 2023-05-01 | Kearney Terrence C Director | Grant or award · Stock Option (Right to Buy) | +3,481 | 3,481 | ||
| 2023-05-01 | Garber Alan M Director | Grant or award | +584 | 6,474 | ||
| 2023-05-01 | Garber Alan M Director | Grant or award · Stock Option (Right to Buy) | +1,741 | 1,741 | ||
| 2023-05-01 | CARNEY LLOYD Director | Grant or award | +1,168 | 5,318 | ||
| 2023-05-01 | Bhatia Sangeeta N. Director | Grant or award 10b5-1 | +1,168 | 5,208 | ||
| 2023-04-27 | Kewalramani Reshma CEO & President | Sale 10b5-1 | −1,611 | $338.69 | $546K | 128,358 |
Page 30 of 40 · 781 trades